fundvisualizer.com

Manning & Napier Overseas Series SMNOSX

Performance (before sales charge)

As of 02/29/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 02/29/2024
Stock
4.91%
Non-U.S. Stock
91.59%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
3.50%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 02/29/2024

Basic materials

6.04%

Consumer cyclical

2.72%

Financial services

15.02%

Real estate

1.14%

Consumer defensive

16.34%

Health care

15.24%

Utilities

0.00%

Communication services

5.86%

Energy

0.00%

Industrials

18.17%

Technology

15.95%

Top 10 holdings

As of 02/29/2024

Taiwan Semiconductor Manufacturing Co Ltd ADR
5.43%
AstraZeneca PLC ADR
4.82%
Samsung Electronics Co Ltd
3.92%
Canadian National Railway Co
3.84%
Deutsche Boerse AG
3.75%
Nestle SA
3.67%
Unilever PLC ADR
3.59%
Novartis AG ADR
3.41%
Heineken NV
3.23%
Dreyfus Government Cash Mgmt Instl
3.21%
Fund assets

$638.54 Million

Share class

S

Morningstar category

Foreign Large Growth

Expense ratio

1.06%

Investment objective

Foreign Stock

Documents
    Compare against similar funds*

    * “Similar funds” are top 10 performing funds in the same Morningstar category and share class , defaulted to 5 Year at NAV.